TORRE, ELEONORA
TORRE, ELEONORA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Selective SERCA2a activator as a candidate for chronic heart failure therapy
2024 Arici, M; Hsu, S; Ferrandi, M; Barassi, P; Ronchi, C; Torre, E; Luraghi, A; Chang, G; Ferrari, P; Bianchi, G; Peri, F; Zaza, A; Rocchetti, M
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
2023 Arici, M; Ferrandi, M; Barassi, P; Hsu, S; Torre, E; Luraghi, A; Ronchi, C; Chang, G; Peri, F; Ferrari, P; Bianchi, G; Rocchetti, M; Zaza, A
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function
2022 Arici, M; Ferrandi, M; Hsu, S; Torre, E; Barassi, P; Luraghi, A; Ronchi, C; Chang, G; Peri, F; Ferrari, P; Bianchi, G; Rocchetti, M; Zaza, A
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy
2022 Torre, E; Arici, M; Lodrini, A; Ferrandi, M; Barassi, P; Hsu, S; Chang, G; Boz, E; Sala, E; Vagni, S; Altomare, C; Mostacciuolo, G; Bussadori, C; Ferrari, P; Bianchi, G; Rocchetti, M
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
2021 Lee, Y; Sala, L; Mura, M; Rocchetti, M; Pedrazzini, M; Ran, X; Mak, T; Crotti, L; Sham, P; Torre, E; Zaza, A; Schwartz, P; Tse, H; Gnecchi, M
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy (DCM)
2021 Torre, E; Arici, M; Lodrini, A; Ferrandi, M; Barassi, P; Hsu, S; Chang, G; Altomare, C; Ferrari, P; Bianchi, G; Rocchetti, M
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
2021 Altomare, C; Lodrini, A; Milano, G; Biemmi, V; Lazzarini, E; Bolis, S; Pernigoni, N; Torre, E; Arici, M; Ferrandi, M; Barile, L; Rocchetti, M; Vassalli, G
The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function
2021 Arici, M; Ferrandi, M; Hsu, S; Torre, E; Barassi, P; Luraghi, A; Ronchi, C; Chang, G; Peri, F; Ferrari, P; Bianchi, G; Rocchetti, M; Zaza, A
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes
2020 Benzoni, P; Campostrini, G; Landi, S; Bertini, V; Marchina, E; Iascone, M; Ahlberg, G; Olesen, M; Crescini, E; Mora, C; Bisleri, G; Muneretto, C; Ronca, R; Presta, M; Poliani, P; Piovani, G; Verardi, R; Pasquale, E; Consiglio, A; Raya, A; Torre, E; Lodrini, A; Milanesi, R; Rocchetti, M; Baruscotti, M; Difrancesco, D; Memo, M; Barbuti, A; Dell'Era, P
Role of SERCA stimulation and voltage-dependent Ca2+ channels in improving Ca2+ handling and sustaining heart automaticity
2020 Torre, E
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes
2017 Rocchetti, M; Sala, L; Dreizehnter, L; Crotti, L; Sinnecker, D; Mura, M; Pane, S; Altomare, C; Torre, E; Mostacciuolo, G; Severi, S; Porta, A; De Ferrari, G; George, A; Schwartz, P; Gnecchi, M; Moretti, A; Zaza, A
Late sodium current and intracellular ionic homeostasis in acute ischemia
2017 Ronchi, C; Torre, E; Rizzetto, R; Bernardi, J; Rocchetti, M; Zaza, A